Acetaminophen 500 MG / chlorpheniramine maleate 4 MG / phenylephrine hydrochloride 10 MG O... — RxCUI 2463332
RxNorm drug concept · Semantic clinical drug
RxCUI 2463332
Semantic clinical drug · SCD
● Current RxNorm concept 6 FDA products
18 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2463332
Official nameAcetaminophen 500 MG / chlorpheniramine maleate 4 MG / phenylephrine hydrochloride 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 500 MG / chlorpheniramine maleate 4 MG / phenylephrine hydrochloride 10 MG Oral Tablet; acetaminophen 500 MG / chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG Oral Tablet
FDA products mapped6
Package NDCs mapped18
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Yes, it's the same active ingredient, but used in very different ways depending on the form. The nasal spray delivers a tiny amount directly to the nasal lining to temporarily shri...
- I see phenylephrine in nasal sprays at the pharmacy AND as an IV drug in the hospital — is it really the same medication?
- You should check with your doctor first. Phenylephrine constricts blood vessels, which can raise blood pressure and put extra strain on the heart — even from a nasal spray. If you...
- Can I use the nasal spray if I have high blood pressure or heart disease?
🕸️ Concept Web — How Acetaminophen 500 MG / chlorpheniramine maleate... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Acetaminophen 500 MG / chlorpheniramine maleate 4 MG / phenylephrine hydrochloride 10 MG Oral Tablet
RxCUI 2463332 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 6
The active substance itself — no strength, form, or brand attached yet.
-
Acetaminophen
161IN -
Chlorpheniramine
2400IN -
Phenylephrine
8163IN -
Acetaminophen / chlorpheniramine / phenylephrine
689583MIN -
Chlorpheniramine maleate
142429PIN -
Phenylephrine hydrochloride
8164PIN
-
Acetaminophen
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Acetaminophen / chlorpheniramine / phenylephrine Oral Tablet
374739SCDF -
Acetaminophen / chlorpheniramine maleate / phenylephrine hydrochloride Oral Tablet
2646973SCDFP -
Acetaminophen / chlorpheniramine / phenylephrine Oral Product
1155249SCDG -
Acetaminophen / chlorpheniramine / phenylephrine Pill
1155250SCDG -
Acetaminophen / chlorpheniramine maleate / phenylephrine hydrochloride Oral Product
2663536SCDGP -
Acetaminophen / chlorpheniramine maleate / phenylephrine hydrochloride Pill
2662311SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Acetaminophen / chlorpheniramine / phenylephrine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Acetaminophen 500 MG
315266SCDC -
Chlorpheniramine maleate 4 MG
998253SCDC -
Phenylephrine hydrochloride 10 MG
996705SCDC
-
Acetaminophen 500 MG
Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Acetaminophen 500 MG
SCDC · 315266 -
Chlorpheniramine maleate 4 MG
SCDC · 998253 -
Phenylephrine hydrochloride 10 MG
SCDC · 996705 -
Acetaminophen / chlorpheniramine / phenylephrine Oral Tablet
SCDF · 374739 -
Acetaminophen / chlorpheniramine maleate / phenylephrine hydrochloride Oral Tablet
SCDFP · 2646973 -
Acetaminophen / chlorpheniramine / phenylephrine Oral Product
SCDG · 1155249 -
Acetaminophen / chlorpheniramine / phenylephrine Pill
SCDG · 1155250 -
Acetaminophen / chlorpheniramine maleate / phenylephrine hydrochloride Oral Product
SCDGP · 2663536 -
Acetaminophen / chlorpheniramine maleate / phenylephrine hydrochloride Pill
SCDGP · 2662311
📦 FDA Products & Package NDCs
6 products · 18 package NDCs
18 package NDCs map to RxCUI 2463332 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 69729-0122-06 | 3 PACKET in 1 CARTON (69729-122-06) / 2 TABLET in 1 PACKET | Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl | OPMX LLC | 2023-09-04 |
| 69729-0122-37 | 12 TABLET in 1 POUCH (69729-122-37) | Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl | OPMX LLC | 2019-08-26 |
| 69729-0122-38 | 144 TABLET in 1 POUCH (69729-122-38) | Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl | OPMX LLC | 2019-08-26 |
| 69729-0133-06 | 3 POUCH in 1 CARTON (69729-133-06) / 2 TABLET in 1 POUCH | COLDTAC ULTRA | OPMX LLC | 2024-01-10 |
| 69729-0133-27 | 2 TABLET in 1 POUCH (69729-133-27) | COLDTAC ULTRA | OPMX LLC | 2024-01-10 |
| 69729-0133-37 | 6 POUCH in 1 CARTON (69729-133-37) / 2 TABLET in 1 POUCH | COLDTAC ULTRA | OPMX LLC | 2024-01-10 |
| 69729-0133-38 | 72 POUCH in 1 CARTON (69729-133-38) / 2 TABLET in 1 POUCH | COLDTAC ULTRA | OPMX LLC | 2024-01-10 |
| 69729-0223-02 | 2 TABLET in 1 POUCH (69729-223-02) | Pentrexcilina Daytime | OPMX LLC | 2020-12-30 |
| 69729-0223-06 | 3 POUCH in 1 CARTON (69729-223-06) / 2 TABLET in 1 POUCH | Pentrexcilina Daytime | OPMX LLC | 2024-01-10 |
| 69729-0223-37 | 6 POUCH in 1 CARTON (69729-223-37) / 2 TABLET in 1 POUCH | Pentrexcilina Daytime | OPMX LLC | 2024-01-10 |
| 69729-0223-38 | 72 POUCH in 1 CARTON (69729-223-38) / 2 TABLET in 1 POUCH | Pentrexcilina Daytime | OPMX LLC | 2020-12-30 |
| 69729-0322-27 | 2 TABLET in 1 POUCH (69729-322-27) | Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl | OPMX LLC | 2019-08-26 |
| 69729-0322-37 | 12 TABLET in 1 POUCH (69729-322-37) | Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl | OPMX LLC | 2019-08-26 |
| 69729-0322-38 | 144 TABLET in 1 POUCH (69729-322-38) | Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl | OPMX LLC | 2019-08-26 |
| 69729-0323-27 | 2 TABLET in 1 POUCH (69729-323-27) | RESFRIOL D | OPMX LLC | 2024-01-10 |
| 69729-0323-37 | 6 POUCH in 1 CARTON (69729-323-37) / 2 TABLET in 1 POUCH | RESFRIOL D | OPMX LLC | 2024-01-10 |
| 69729-0323-38 | 72 POUCH in 1 CARTON (69729-323-38) / 2 TABLET in 1 POUCH | RESFRIOL D | OPMX LLC | 2024-01-10 |
| 69729-0829-30 | 1 BLISTER PACK in 1 CARTON (69729-829-30) / 30 TABLET in 1... | DESENFRIOL D | OPMX LLC | 2026-06-18 |
Observed labelers:
OPMX LLC (18)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.